This phase I trial studies the side effects and how well high dose vitamin A works in preventing gastrointestinal graft versus host disease (GVHD) in participants undergoing donor stem cell transplant. Vitamin A deficiency is associated with increased risk of gastrointestinal GVHD. Vitamin A regulates growth and differentiation of intestinal cells and may reduce risk of gastrointestinal GVHD.
PRIMARY OBJECTIVES:
I. To assess the feasibility and safety of pre-transplant single, high dose vitamin A supplementation in adult allogeneic stem cell transplant recipients until day +28 after transplant.
OUTLINE: This is a dose-escalation study.
Participants receive vitamin A compound orally (PO) or enterally once prior to stem cell transplant.
After completion of study treatment, participants are followed up periodically.
Condition | Allogeneic Hematopoietic Stem Cell Transplantation Recipient |
---|---|
Treatment | Vitamin A Compound |
Clinical Study Identifier | NCT03719092 |
Sponsor | Ohio State University Comprehensive Cancer Center |
Last Modified on | 7 February 2023 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.